BMJ Open · 2012 · 278 citations · 14 references
Dapagliflozin appears effective in reducing HbA1c and weight in type 2 diabetes, although more safety data are needed.
14
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001
Ali H. Mokdad, Earl S. Ford, Barbara A. Bowman et al. · JAMA · 2003 · 5.9K citations
Jan Bolinder, Östen Ljunggren, Joel Kullberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 849 citations
Clifford J. Bailey, Jorge Luiz Gross, Anne Pieters et al. · The Lancet · 2010 · 848 citations
Metabolic Syndrome, Diabetes Management, Inadequate Glycaemic Control +6